ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 64750 | ISO 10993-18:2020 | Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process | Standarts spēkā |
| 64744 | ISO/PWI 10993-17 | Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substances | Izstrādē |
| 64582 | ISO 10993-16:2017 | Biological evaluation of medical devices — Part 16: Toxicokinetic study design for degradation products and leachables | Standarts spēkā |
| 64581 | ISO/PWI 10993-13 | Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices | Izstrādē |
| 64580 | ISO 10993-9:2019 | Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products | Standarts spēkā |
| 64238 | ISO/DTR 17137-2 | Cardiovascular implants and extracorporeal systems — Cardiovascular absorbable implants — Part 2: Guidance on biological evaluation of absorbable implants | Izstrādē |
| 63449 | ISO/CD 10993-5 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | Izstrādē |
| 63448 | ISO 10993-4:2017 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | Standarts spēkā |
| 61089 | ISO 10993-6:2016 | Biological evaluation of medical devices — Part 6: Tests for local effects after implantation | Standarts spēkā |
| 59992 | ISO 14155:2011/Cor 1:2011 | Clinical investigation of medical devices for human subjects — Good clinical practice — Technical Corrigendum 1 | Atcelts |
Displaying 81-90 of 159 results.